Diabetes Care Devices Market Size, Growth, Share & Trends Analysis

A high prevalence of diabetes continues to be a key driver for the growth of the diabetes care devices market worldwide. The 2024 World Diabetes Day theme, “Breaking Barriers, Bridging Gaps”, highlights the urgent need to address the growing diabetes burden, especially in the WHO’s South-East Asia Region, where nearly 246 million adults are affected (2022). Over 60% remain undiagnosed, putting them at risk of severe complications like heart disease, kidney failure, and blindness. Progress is underway, with 23 million patients already on protocol-based care by mid-2024, moving toward the SEAHEARTS goal of 100 million on standard treatment by 2025. The IDF Diabetes Atlas 2025 reveals that 11.1% of adults (1 in 9) live with diabetes, with over 40% undiagnosed. By 2050, cases are projected to rise by 46%, affecting 1 in 8 adults (≈853 million). Over 90% have type 2 diabetes, largely influenced by socio-economic, demographic, environmental, and genetic factors. According to the above-mentioned data, the prevalence of diabetes is rising at an alarming rate, affecting millions of people across all age groups. The increasing cases are mainly due to changes in lifestyle, unhealthy dietary habits, and urbanization. As the number of people affected with diabetes increases the growing need for effective tools and diabetes management also increases.

Concerns related to high-cost act as a notable restraint in the diabetes care devices market. The advanced products such as insulin pumps, continuous glucose monitoring systems, smart insulin pens provide with superb accuracy and can be used with utmost convenience but are priced higher. These devices also require recurring expenses on related consumables such as the glucose strips cartridges which lead to an added financial burden. The situation is more challenging in few countries where the reimbursement policies are limited, making such technologies and products accessible only to a specific population. The higher cost of the devices decreases the penetration of the innovative technologies and also increases the gap between those who have access to advanced care and those who have to use the less efficient monitoring methods. Consequently, the high cost of diabetes care devices continues to act as a major restraint on overall market expansion.

The recent advancements, such as the patient-implantable continuous glucose monitoring devices, present a great opportunity for the diabetes care devices market and help in better diabetes management as they offer long-term, reliable glucose monitoring without the need for frequent replacement of the sensors. These devices make it very convenient for the patient as they reduce the burden of daily management and frequent changing of sensors. The implantable continuous glucose monitoring systems reduce the skin irritation issues, which are more common with the adhesive-based sensors, and provide the individual with freedom while performing daily activities. Also, their seamless integration with mobile applications and various digital health platforms provides continuous real-time monitoring and alerts to educate the patient about their health condition.

One of the significant challenges in the diabetes care devices market is the relatively short life span of the continuous glucose monitors, which last only 7 to 14 days; also, the frequent sensor replacement poses a challenge, leading to a financial burden. This issue is seen on a larger scale in low- and middle-income countries where the health infrastructure is limited, the reimbursement rate is lower, and higher out-of-pocket expenditure makes the technological advancement expensive. This leads to a larger portion of the population being inaccessible to the advanced technologies, which not only affects individual health but also constrains the overall market penetration.